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The mosquito-transmitted bunyavirus, Rift Valley fever virus
(RVFV), is a highly successful pathogen for which there are no
vaccines or therapeutics. Translational arrest is a common antiviral
strategy used by hosts. In response, RVFV inhibits two well-known
antiviral pathways that attenuate translation during infection, PKR
and type I IFN signaling. Despite this, translational arrest occurs
during RVFV infection by unknown mechanisms. Here, we find that
RVFV infection triggers the decay of core translation machinery
mRNAs that possess a 5′-terminal oligopyrimidine (5′-TOP) motif in
their 5′-UTR, including mRNAs encoding ribosomal proteins, which
leads to a decrease in overall ribosomal protein levels. We find that
the RNA decapping enzyme NUDT16 selectively degrades 5′-TOP
mRNAs during RVFV infection and this decay is triggered in response
to mTOR attenuation via the translational repressor 4EBP1/2 axis.
Translational arrest of 5′-TOPs via 4EBP1/2 restricts RVFV replication,
and this increased RNA decay results in the loss of visible RNA gran-
ules, including P bodies and stress granules. Because RVFV cap-
snatches in RNA granules, the increased level of 5′-TOP mRNAs in
this compartment leads to snatching of these targets, which are
translationally suppressed during infection. Therefore, translation
of RVFV mRNAs is compromised by multiple mechanisms during in-
fection. Together, these data present a previously unknown mecha-
nism for translational shutdown in response to viral infection and
identify mTOR attenuation as a potential therapeutic avenue against
bunyaviral infection.
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As obligate intracellular parasites with limiting coding ca-pacity, viruses must use host complexes and pathways to
replicate. One hijacked pathway is the host translational ma-
chinery; all viruses depend on ribosomes for the translation of
their mRNAs. This dependency has led to the evolution of
translational arrest as a robust antiviral mechanism (1, 2). PKR
inhibits global translation through the phosphorylation of a
major factor in translation initiation, EIF2A. Phosphorylation
of EIF2A stabilizes the EIF2–EIF2B–GDP complex, thereby
inhibiting the GTP exchange and Met-tRNAi
MET binding re-
quired for further rounds of translation initiation (2, 3). Fur-
thermore, type I interferons (IFNs), which are rapidly induced
during many viral infections, lead to the induction of a large
panel of IFN-stimulated genes (ISGs), including IFIT proteins,
which inhibit translation initiation at multiple steps (1). To
counter these mechanisms, many viruses overcome or subvert
these responses, including via the inhibition of PKR and IFN
signaling. Furthermore, viruses can bypass these mechanisms by
accessing the translational apparatus using noncanonical ap-
proaches such as the internal ribosome entry sites of flaviviruses,
such as hepatitis C virus, which bypasses requirements for many
translation initiation factors (4).
In addition to inhibiting viral infection, translational arrest is
a conserved cellular mechanism to cope with diverse cellular
stressors, including chemical and environmental challenges (5).
Although global changes in protein synthesis or RNA decay are
regulated, increasing evidence suggests that there is also speci-
ficity, in that functionally related mRNAs can be synchronously
regulated at the level of translation or RNA stability (6, 7).
Coordinated changes in the translation and stability of cohorts of
genes have been linked to specific RNA-binding proteins and
conserved cis elements within the untranslated regions (UTRs)
(6). These “RNA operons” have been well-established for some
classes of genes, including cell cycle-regulated replicating histone
mRNAs, controlled by the levels of stem-loop binding protein
(SLBP) (8). In immunity, the RNA binding proteins ELAV/Hu
and TTP target chemokine and cytokine mRNAs and alter
their stability (6), and the half-lives of these RNAs are synchro-
nously regulated during immune responses (6). Furthermore, evi-
dence in yeast demonstrates that the individual components of
complexes, including the ribosome, have incredibly similar
mRNA half-lives (7), suggesting coordinate regulation of their
stability. As much of the modulation of gene expression occurs
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posttranscriptionally, these downstream regulatory mechanisms
have the advantage of a specific and rapid response to stimuli.
Arthropod-borne viruses (arboviruses) are a subset of viruses
that are transmitted from arthropods (typically a mosquito or
tick) to mammals; to productively infect such disparate hosts,
these viruses have adapted to use highly conserved pathways
while evading the immune responses of both hosts. The mos-
quito-transmitted bunyavirus Rift Valley fever virus (RVFV) is a
highly successful pathogen: it has developed evasion strategies
that lead to the inhibition of PKR activity (9) and blocks the
activation of type I IFNs (10). Furthermore, RVFV gains access
to host ribosomes by “cap-snatching” the 5′ ends of host
mRNAs. During viral mRNA transcription in the cytoplasm,
host mRNA caps are recognized by the viral nucleocapsid pro-
tein (N) and cleaved 10–18nt downstream of the 5′ cap by the
viral polymerase (L), which has endonuclease activity (11–14).
This capped oligomer is then used as the primer for viral tran-
scription. By masking its 5′ ends using endogenous caps, RVFV
evades host pattern recognition receptors (PRRs) while effi-
ciently accessing host ribosomes (15). It is thought that cap-
snatching occurs within cytoplasmic RNA granules known as
processing bodies (P bodies): RVFV N associates with P bodies
in insect cells, and another bunyavirus, Sin Nombre virus, lo-
calizes to P bodies in human cells (16, 17).
Here, we find that RVFV infection leads to global shutdown
of translation through the specific decay of the core translational
machinery, including ribosomal protein mRNAs. A feature of
these translationally related mRNAs, including the core trans-
lation machinery, is the presence of 5′-terminal oligopyrimidine
(5′-TOP)–containing sequence at the extreme 5′ terminus of
their mRNAs (18–20). This motif is conserved (21) and has been
defined as a 5′-terminal cytosine followed by four pyrimidines
(18, 19, 22). Recent work demonstrated that this classical 5′-TOP
motif definition may be too strict, as mRNAs containing
5′-TOP–like motifs (mRNAs containing a series of five pyrimidines
beginning within four bases of the 5′ end) behave similarly to
bona fide 5′-TOP–containing mRNAs in regard to regulation of
their translation (23). Previous studies showed that these 5′-TOP
mRNAs are translationally regulated by mTOR signaling and its
downstream target 4EBP which inhibits cap-dependent trans-
lation by binding to the translation initiation factor eIF4E (23,
24). Upon attenuation of mTOR signaling, these mRNAs are no
longer associated with polysomes and are relocalized to stress
granules (25), where mRNAs are translationally stalled but not
degraded (26). Indeed, mTOR inhibition is not sufficient to
decrease the stability of these mRNAs. We find that RVFV in-
fection leads to the attenuation of mTOR signaling, activating
4EBP to inhibit translation, and under these conditions also
induces the decay of 5′-TOP mRNAs. This suggests that viral
infection sends two complementary signals. The first leads to
mTOR attenuation, relocalizing 5′-TOP mRNAs to stress
granules where their translation is stalled, and the second signal
sends these mRNAs for degradation in P bodies, where the
decapping and other RNA decay machinery resides. Although
there are two well-characterized decapping enzymes, we found
that NUDT16 selectively targets 5′-TOP mRNAs for decay. We
also found that there is a second consequence to this induced
decay: because RVFV cap-snatching machinery resides in P
bodies, the virus snatches 5′-TOP mRNAs, thus making these
viral mRNAs less suitable for translation. Altogether, these data
suggest that coordinate decay of 5′-TOP mRNAs attenuates
translation at multiple levels and restricts RVFV infection.
Results
RVFV Induces 5′-TOP mRNA Loss. Although it has been demon-
strated that RVFV infection inhibits protein production during
infection of mammalian cells (27), the mechanism is unknown as
RVFV inhibits the two canonical antiviral pathways that block
translation in response to viral infection, PKR and IFN (9, 10).
Previous reports have demonstrated that the translation of
5′-TOP mRNAs is inhibited in response to a variety of stresses
including attenuation of mTOR signaling (25), thus inhibiting
global translation because many 5′-TOP mRNAs encode the
translation machinery. Therefore, we examined whether RVFV
infection impacted the basal levels of a panel of endogenous
5′-TOP–containing mRNAs during infection. We found a greater
than twofold decrease in the levels of 5′-TOP–containing
mRNAs 24 h after RVFV infection in U2OS cells, a human
osteosarcoma cell line that is permissive to RVFV infection (Fig.
1A). This decrease in 5′-TOP mRNAs was also reflected at the
protein level, as immunoblot analysis showed decreased RPS3A
and RPS8 protein expression upon RVFV infection (Fig. 1B).
Levels of mRNAs lacking a 5′-TOP (Fig. S1A) and 28S rRNA
remained stable in RVFV-infected cells (Fig. 1A). We confirmed
that this was generalizable to other mammalian systems by
infecting mouse embryonic fibroblasts (MEFs) with RVFV and
observed decreased levels of 5′-TOP mRNAs and decreased
protein levels upon infection (Fig. 1 C and D).
We next examined whether loss of 5′-TOP mRNAs was de-
pendent on RVFV replication. We found no change in 5′-TOP
mRNA levels in U2OS cells treated with UV-killed RVFV,
whereas WT virus dramatically decreased RPS3A and RPS8
mRNA levels (Fig. 1E). Altogether, these results demonstrate
that infection with replication-competent RVFV leads to the loss
of 5′-TOP mRNAs accompanied by a decrease in the expression
levels of the translation machinery.
5′-TOP mRNAs Have Decreased Stability During RVFV Infection. Next,
we determined whether RVFV infection impacted transcription
of 5′-TOP mRNAs or their stability. For these studies, we ex-
amined the decay rate of 5′-TOP mRNAs or mRNAs lacking a
5′-TOP during RVFV infection. Normally, ribosomal protein
mRNAs are stable, with half-lives in the range of 12 h in mam-
mals (28), which we hypothesized would be reduced upon in-
fection. U2OS cells were infected with RVFV for 17 h, and then
treated with actinomycin D (ActD) to inhibit mRNA transcrip-
tion. Given the long half-lives of these mRNAs, total RNA was
collected at 3-h intervals and analyzed by reverse transcription–
quantitative real-time PCR (RT-qPCR). Although we observed
little decay of RPL24 (Fig. 2A), RPS3A (Fig. 2B), or RPS8 (Fig.
2C) mRNA in uninfected cells treated with ActD over 9 h, all
three mRNAs showed increased decay during RVFV infection
(P < 0.001; Fig. 2 A–C). In contrast, there was no change in the
decay rate of two mRNAs lacking a 5′-TOP (Fig. S1 B and C).
Therefore, RVFV infection induces 5′-TOP mRNA decay,
resulting in decreased 5′-TOP mRNA and protein levels during
infection.
RVFV Inhibits 5′-TOP mRNA Translation Early in Infection, Followed
by Global Translation Inhibition. We next sought to determine
whether this decay was specific to mRNAs containing a 5′-TOP
motif, and whether that motif was necessary and sufficient for
RVFV-induced mRNA decay. Human U2OS cells were trans-
fected with reporter constructs containing an EEF2 5′-UTR
upstream of a luciferase reporter, encoding either its native
5′-TOP motif (TOP-WT) or a mutated 5′-TOP UTR (TOP-MUT)
(23). Twenty-four hours after transfection, cells were infected
with RVFV [multiplicity of infection (MOI), 5] for 16 h, and
luciferase activity was analyzed. We found that luciferase activity
from the WT 5′-TOP reporter was decreased upon infection
similar to the endogenous 5′-TOPs. Furthermore, the MUT re-
porter was less sensitive to infection induced changes in trans-
lation, translating significantly more efficiently than the WT
5′-TOP during infection (Fig. 2D).
Because the loss of the core translation machinery due to the
decay of 5′-TOP mRNAs (Fig. 1) should ultimately impact
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translation globally, as observed by Brennan et al. (27), we hy-
pothesized that at later time points postinfection the translation
of both 5′-TOP mRNAs and non–5′-TOP mRNAs would be
similarly impacted. Therefore, we monitored translation from
our reporters at a later time [24 h postinfection (hpi)] and found
that translation of both the TOP-WT and TOP-MUT constructs
were attenuated to the same degree during infection (Fig. 2E).
Altogether, these data suggest that RVFV initially inhibits the
translation of 5′-TOP mRNAs, subsequently leading to an in-
hibition of global protein translation.
RVFV Infection Attenuates mTOR Signaling and Activates 4EBP1.
Recent studies have revealed that the translation of 5′-TOP–con-
taining mRNAs is under the control of mTOR via the 4EBP1/2
axis (23). Translational efficiency of 5′-TOP mRNAs is inhibited by
the ATP-competitive mTOR inhibitor Torin 1, which is dependent
on the 5′-TOP mRNA cis element (23). Furthermore, we recently
showed that RVFV infection attenuates Akt signaling (29), a
known upstream activator of the mTORC1 complex. Therefore, we
determined the activation status of the mTOR pathway, and in
particular 4EBP1, during RVFV infection. We found that the
mTOR pathway was attenuated during RVFV infection in
MEFs: the phosphorylation status of Akt, and of two downstream
targets of mTOR (RpS6 and 4EBP1) was reduced 18 hpi, whereas
total levels were unaffected (Fig. 3A). This timing is coincident with
a significant decrease in 5′-TOP mRNA and protein production
(Fig. 1 C and D).
4EBP1/2 Is Required for 5′-TOP mRNA Decay and Controls RVFV
Infection. mTOR regulates 5′-TOP mRNA translation through
phosphorylation and inactivation of 4EBP1/2 (19, 23–25, 30, 31).
Therefore, we hypothesized that RVFV-induced decay of
5′-TOP–containing mRNAs is dependent upon initial translational
shutdown of these mRNAs via 4EBP1/2. To test this model, we
obtained MEFs deficient in 4EBP1/2 [4EBP1/2 double knockout
(DKO)] (23, 24) and examined the decay of 5′-TOP mRNAs
during RVFV infection of WT or 4EBP1/2 DKO MEFs. We
found that, at 20 hpi, although EEF2 and RPS3A mRNA levels
both decreased in WT MEFs, no change was observed in these
5′-TOP–containing mRNAs in infected 4EBP1/2 DKO MEFs
(Fig. 3B). This suggests that RVFV-induced decay of 5′-TOP
mRNAs is 4EBP dependent and is likely preceded by the se-
lective translational shutdown of these messages (Fig. 2D).
Translational shutdown is a common mechanism used by cells
to restrict viruses (1, 2, 32), suggesting that the RVFV-triggered
decay of 5′-TOP mRNAs and ribosomal proteins is a cellular
response to inhibit RVFV infection. Therefore, we examined
whether the loss of 4EBP1/2 impacted RVFV replication. In-
deed, when we compared 4EBP1/2 mutant MEFs to their con-
trols, we observed significantly increased viral infection as mea-
sured by microscopy (approximately fourfold; Fig. 3 C and D).
Therefore, 4EBP1/2 controls both 5′-TOP translation and
RVFV infection.
Although others have shown that direct mTOR inhibition
leads to the translational arrest of 5′-TOP mRNAs (18, 22, 23),
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Fig. 1. RVFV infection leads to decreased 5′-TOP
mRNA and ribosomal proteins. (A) U2OS cells were
infected with RVFV (MOI, 2) for 24 h and total RNA
was collected and analyzed by RT-qPCR. Fold change
in 5′-TOP mRNA signal is indicated compared with
uninfected U2OS cells as normalized to 28S rRNA
with mean ± SD (n = 3; *P < 0.05). (B) U2OS cells
were treated as in A, and total protein was collected
and analyzed by immunoblot. (C) Murine embryonic
fibroblasts (MEFs) were infected with RVFV (MOI, 2)
for 20 h, and total RNA was collected and analyzed
by RT-qPCR. Fold change in 5′-TOP mRNA signal is
indicated compared with uninfected MEFs as nor-
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0.05). (D) MEFs were infected with RVFV (MOI, 2) for
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by immunoblot. (E) U2OS cells were infected with WT
or UV-killed RVFV (MOI, 50–100) for 24 h, and total
RNA was collected and analyzed by RT-qPCR. Fold
change in RPS8 mRNA or RPS3A mRNA is indicated
compared with uninfected U2OS cells as normalized
to 28S rRNA with mean ± SD (n = 3; *P < 0.05).
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the decay of these mRNAs has not been observed. Therefore, we
tested whether inhibition of mTOR was sufficient to induce
decay of 5′-TOP mRNAs in our system. We found that treatment
with the inhibitor Torin 1 (up to 24 h) had no impact on the
levels of 5′-TOP–containing ribosomal protein mRNAs in MEFs
(Fig. 3E), whereas RPS3A protein levels were decreased 18 h
after Torin 1 treatment, consistent with previous reports (Fig. 3F)
(23). Altogether, these data suggest that mTOR inhibition by
RVFV leads to 4EBP1/2 activation which is necessary but not
sufficient for RVFV-induced 5′-TOP mRNA decay. This sug-
gests that a second virus-induced signal is required for 5′-TOP
mRNA decay.
RNA Granules Are Regulated by RVFV Infection. To orchestrate
RNA storage and RNA decay, the cell assembles RNA–protein
complexes called RNA granules. There are two classical RNA
granules that play interrelated roles in the cell: stress granules,
which store translationally stalled mRNAs, and P bodies, which
house the mRNA decay machinery where many mRNAs are
decapped and degraded (26). These RNA granules are highly
dynamic and tightly regulated; accumulation of mRNAs in these
structures leads to the formation of visible punctae (33, 34),
whereas increased RNA decay leads to their disaggregation
without loss of activity (34). Furthermore, many diverse cellular
insults cause stress granules to dock with and/or evolve into P
bodies leading to the decay of resident RNAs (35, 36). Because
5′-TOP mRNAs have been shown to accumulate in stress gran-
ules upon inhibition of mTOR signaling (25), we reasoned that a
RVFV-induced signal may lead to changes in these RNA gran-
ules, which would result in the decay of 5′-TOP mRNAs in P
bodies. Therefore, we examined the architecture of RNA gran-
ules during RVFV infection by microscopy. We monitored these
RNA granules in the presence and absence of infection using
arsenic, which rapidly induces visible stress granules and P bodies
(35). Within 30 min of arsenic treatment of U2OS cells, we
observed a strong induction of stress granules using a panel of
stress granule-associated proteins (G3BP, TIAR, and eIF4G)
and P bodies using a panel of P-body–associated proteins
(DCP1a, DCP2, and Rck/DDX6) (Fig. 4 A and B; quantified in
Fig. S2A). However, in RVFV-infected cells, there was a sig-
nificant loss of both stress granule and P-body punctae induction
(Fig. 4 A and B; quantified in Fig. S2A). Furthermore, we found
that this was cell autonomous, as only the infected cells lacked
RNA granules (Fig. 4C).
The inability of RNA granules to form in RVFV-infected cells
in response to arsenic treatment could indicate a specific defect;
indeed, RNA granules can have differing protein composition
depending upon the stimulus used for induction (35). Therefore,
we tested whether RNA granules could be induced by other
insults during RVFV infection. Cells were either mock treated or
infected with RVFV for 12 h and exposed to heat shock or hy-
drogen peroxide. We found that Rck-containing granules were
unable to form in response to either of these stimuli in infected
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Fig. 2. RVFV induces 5′-TOP mRNA decay. (A–C) U2OS cells
were infected with RVFV (MOI, 1) for 17 h, and then treated
with ActD (5 μg/mL) for the indicated number of hours. Total
RNA was collected at each time point and analyzed by RT-qPCR
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containing RPL24 (*P = 0.0013). (B) 5′-TOP–containing RPS3A
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expressing either the WT TOP-containing EEF2 5′-UTR or a TOP-
mutant UTR, and then untreated or infected with RVFV (MOI,
5). (D) Luciferase expression was measured 16 hpi. Mean ± SD is
shown (n = 3; *P < 1E-3). (E) Luciferase expression was mea-
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cells, suggesting a general defect in RNA granule accumulation
(Fig. S2 B and C) (35, 37).
RNA Granule-Resident Protein Levels Are Not Altered During RVFV
Infection. The dispersal of RNA granules could be due to a loss
of RNA granule-resident proteins required for assembly (38) or
due to a loss in resident mRNAs necessary for nucleation (34).
Indeed, P-body granule aggregation into visible punctae is not
necessary for the decay functions that occur in P bodies, and
increased mRNA decapping leads to the loss of visible P-body
granules and continued RNA decay (33, 34). Additionally,
translation complexes can be stalled in the absence of visible
stress granules (39). Therefore, we first examined the steady-
state levels of a panel of RNA granule-resident proteins during
RVFV infection by immunoblot. We found no change in the
levels of P-body proteins (DCP2, Rck/DDX6, or DCP1a) or
stress granule proteins (TIAR, eIF4G, G3BP) in U2OS cells
infected with RVFV at 8, 18, or 24 hpi compared with uninfected
cells (Fig. 4D). These data, together with our data showing de-
creased stability of 5′-TOP mRNAs, suggest that the loss of
visible RNA granules is likely due to RVFV-induced signals in-
creasing mRNA decay activity.
RNA Granule Dispersal Is Sequential During RVFV Infection. If RNA
granule disaggregation was indeed due to increased mRNA de-
cay, we might expect that stress granules would be depleted
before P bodies as the 5′-TOP mRNAs were sent from the stress
granules to P bodies for degradation. Therefore, we explored the
kinetics of RNA granule loss during RVFV infection. We treated
cells with arsenic at 0, 4, 6, 8, 10, and 12 hpi and monitored RNA
granule formation. These experiments revealed that the accu-
mulation of stress granules was impacted before P bodies, as
early as 6 hpi (Fig. 4 E and F). Although Rck punctae remained
6–8 hpi, there was a significant loss in TIAR punctae (Fig. 4F);
additionally, we observed close proximity of those remaining
stress granules and P bodies in infected cells at 6 hpi (see close
apposition of red and green in Fig. 4E). This suggests that stalled
translation complexes are first accumulated in stress granules as
previously reported, and the RNA is subsequently shuttled to P
bodies for degradation, made possible by their tight interaction
(35). The order of disappearance of the punctae supports this
directionality.
This led us to examine whether RNA granule dispersal was
dependent on viral replication. To this end, we treated cells with
UV-inactivated RVFV and observed no impact on arsenic-induced
RNA granule accumulation (Fig. S2D), consistent with our ob-
servation that UV-inactivated RVFV is insufficient to trigger
5′-TOP mRNA decay (Fig. 1E), suggesting that the second signal
that induces both RNA granule dispersal and 5′-TOP mRNA de-
cay is replication dependent and occurs as early as 6 hpi.
NUDT16 Selectively Targets 5′-TOP mRNAs. We found that RNA
granules are dispersed in a sequential manner, and because granule-
resident proteins are not degraded during RVFV infection, this
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suggests that decay of nucleating RNAs is responsible for the dis-
persal, consistent with the decreased stability of 5′-TOP mRNAs.
Therefore, we next examined whether the P-body–resident RNA
decapping machinery is involved (40). In mammals, there are two
characterized decapping enzymes, the canonical decapping enzyme
DCP2, and the more recently identified NUDT16 (41). The specific
mRNA targets for these decapping enzymes are not completely
understood; it is thought that they have both unique and over-
lapping targets (42–44). We examined whether the mRNA
decapping enzymes DCP2 or NUDT16 control the levels of 5′-TOP
mRNAs using the 5′-TOP luciferase reporters. We transiently
expressed either Flag-tagged NUDT16 (41) or GFP-tagged DCP2
(45) (Fig. S3 A and B) and found that ectopic expression of either
NUDT16 or DCP2 decreased levels of luciferase from 5′-TOP
mRNAs (Fig. 5A, TOP-WT), suggesting that both decappers are
limiting and can decay these substrates. Intriguingly, although
enforced expression of DCP2 decreased luciferase levels from a
mutant 5′-TOP reporter (TOP-MUT), increasing NUDT16 levels
had no effect (Fig. 5A), suggesting specificity for this decapping
enzyme. We also examined the effects of siRNA depletion of DCP2
and NUDT16 (Fig. S3 C and D) on luciferase reporters. In contrast
to ectopic expression (Fig. 5A), DCP2 depletion did not affect lu-
ciferase expression of either the WT or mutant TOP reporter (Fig.
5B). However, NUDT16 depletion led to a specific increase in
TOP-WT, but not TOP-MUT luciferase expression (Fig. 5B).
Overall, these data suggest that 5′-TOP mRNAs are a selective
target of NUDT16-dependent decay.
RVFV Cap-Snatches from 5′-TOP mRNAs. Data suggest that bunyavi-
ruses cap-snatch mRNAs targeted to P bodies (16, 17). Therefore,
we hypothesized that RVFV would cap-snatch 5′-TOP mRNAs
targeted for degradation in infected human cells. We performed
5′-RACE to sequence the 5′ end of viral mRNAs and identified
119 snatched sequences that aligned with the human genome at
5′-UTRs (Table S1) (16). The mean length of endogenously cap-
snatched sequences was 13.2 nt (SD, ±1.7) (Fig. S4A); this is
consistent with previous reports that placed bunyaviral cap-
snatching products between 10 and 18 nt (46). Informatic analysis
suggested an overall preference for snatching endogenous host
mRNAs with pyrimidines at their 5′ end, a signature of 5′-TOP
mRNAs (Fig. S4 B and C). Gene Ontology enrichment analysis
revealed that cap-snatched sequences were enriched for genes in-
volved in mRNA translation (P = 2E-24; Fig. S4D), including
mRNAs encoding core components of the translation machinery,
such as protein components of the ribosome and translation initi-
ation and elongation factors that contain 5′-TOPs (Table S1 and
Fig. S4 D and E). As recent reports have shown that the classical
5′-TOP motif definition may be too strict, we included mRNAs
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containing 5′-TOP–like motifs (mRNAs containing a series of
five pyrimidines beginning within four bases of the 5′ end) in our
analysis as they have been demonstrated to be regulated at the
translational level identically to classical 5′-TOP–containing
mRNAs (23). Previous reports have estimated that, in mice,
based on well-annotated 5′-UTRs, ∼16% of mRNAs in the genome
encode 5′-TOP or 5′-TOP–like motifs (23). We observed that
greater than 35% of the mRNAs cap-snatched by RVFV in human
cells contained 5′-TOP motifs and that this enrichment was highly
significant (Fig. 5C, P = 1E-7). Indeed, we found many cap-
snatched sequences were from canonical examples of 5′-TOP motifs
(Fig. 5D). These data show that 5′-TOP–containing mRNAs are
indeed targeted to P bodies, where the viral cap-snatching ma-
chinery incorporates them into viral mRNAs. The targeting of genes
with this motif explains the observed bias toward pyrimidines at the
5′ end of snatched mRNAs (Fig. S4B).
Incorporation of 5′-TOP–Containing mRNA Caps into RVFV N mRNA Is
Limited by NUDT16. Next, we examined whether the decapping
enzymes may selectively impact the ability of RVFV to snatch
5′-TOP mRNA targets. Because NUDT16 had a selective pref-
erence for 5′-TOPs (Fig. 5 A and B), we reasoned that depletion
of NUDT16 would lead to increased snatching of these targets.
U2OS cells were depleted of either DCP2 or NUDT16 (Fig. S3
C and D), and infected with RVFV for 20 h, and total RNA was
examined by RT-qPCR using a primer strategy to amplify spe-
cific host mRNAs that are cap-snatched (16). Briefly, a forward
primer containing a linker followed by 10–18 bp of the extreme
5′ end of the indicated 5′-TOP–containing endogenous mRNA
was used with a reverse primer specific for RVFV N RNA. Ex-
amination of a panel of seven 5′-TOP-RVFV N mRNA conju-
gate mRNAs revealed that siRNA depletion of NUDT16 led to
at least a fivefold increase in the levels of all conjugates tested
(Fig. 5E). Conversely, although DCP2 depletion led to an overall
trend in increased TOP-N conjugates, only three were significant,
and the increase was maximally threefold (Fig. 5E). This suggests
that RVFV mRNA snatching of these 5′-TOP caps is limited by
decapping and, when taken in combination with reporter assay
results (Fig. 5 A and B), suggests that NUDT16 is the primary
decapping enzyme for 5′-TOP mRNAs in human cells.
Discussion
We found a clear interplay between RVFV infection, mTOR
signaling, and translational arrest via 5′-TOP mRNA decay,
suggesting the model depicted in Fig. S5. During RVFV in-
fection, recognition of a viral PAMP on the incoming virus serves
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as a signal to attenuate Akt–mTOR signaling (Fig. 3A) (29). This
leads to increased 4EBP1/2 activity, inhibiting the translation of
TOP mRNAs and sending them to stress granules (23). Because
attenuation of the mTOR pathway is not sufficient for 5′-TOP
decay (Fig. 3E), nor RNA granule dispersal (Fig. S2E), we sug-
gest that viral infection produces a second signal that induces the
relocalization of 5′-TOP mRNAs to sites where the decapping
machinery is present, which then results in the decay of these
5′-TOP mRNAs and the loss in RNA granule architecture.
We suggest that the decay of 5′-TOP mRNAs during RVFV
infection leads to the decreased ribosomal protein levels we
observed in Fig. 1 B and D, as well as decreased protein levels of
other 5′-TOP mRNAs, which include many translation initiation
and elongation factors. This in turn results in decreased levels of
global translation (Fig. 2E). The half-lives of the plethora of
translation factors are not known, but it is known that ribosomal
proteins are very stable when integrated into ribosomes, with
half-lives on the order of days in some tissues (47). However, it
has been demonstrated that newly translated ribosomal proteins
in the nucleolus are in excess for ribosome biogenesis and that it
is the levels of rRNA that are rate-limiting for ribosomal as-
sembly; thus, ribosomal proteins that are not complexed are
rapidly degraded (48). Despite the longevity of cytoplasmic ri-
bosomes, even transient changes in 5′-TOP mRNA translation
during circadian rhythm cycling impact global translation (49).
Indeed, even a 20% reduction in overall translation is sufficient
to impact the levels of relatively stable housekeeping genes (49),
suggesting that the larger decreases we see in ribosomal protein
levels during RVFV infection (Fig. 1 B and D) are sufficient to
explain both the decreased levels of global translation we ob-
serve (Fig. 2E) and the ability of 4EBP1/2 to restrict RVFV in-
fection (Fig. 3 B–D). We therefore suggest that the decay of
5′-TOPs results in ribosomal proteins and other translation factors
becoming rate-limiting for translation, and that during RVFV
infection global translation is attenuated due to this decay.
Because inhibition of mTOR is not sufficient to induce decay
(Fig. 3E), we suggest that under conditions where mTOR sig-
naling is attenuated in the absence of the second virus-induced
signal, the 5′-TOP mRNAs are transiently sequestered into stress
granules and can be subsequently returned to the pool of
translating mRNAs once the stress has been alleviated. This
potential ability to store and subsequently reuse translational
mRNAs may be beneficial (28); regenerating core translation
mRNAs would be energetically costly in situations of transient
stress. Indeed, in yeast it has been observed that translational
arrest due to external stressors generally leads to increased
mRNA stability, allowing time for the cell to assess the stress
before launching an appropriate gene program (50). During viral
infection, which is a strong insult that can ultimately be de-
structive, 5′-TOP mRNA decay would result in a more perma-
nent inhibition of translation and eventually lead to loss of cell
viability. We observed changes in RNA granules at 6 hpi (Fig.
4F), suggesting that if viral infection is not overcome by this time
point the cell will shut down translation through a more per-
manent mechanism, perhaps leading to the destruction of the
virally infected cell. Although we did not observe any loss in cell
number during our studies, others have observed RVFV-induced
cell death at later time points (51). Indeed, translational arrest by
other antiviral pathways including PKR and IFN also ultimately
results in the death of virally infected cells to prevent the spread
of the infection from the initial infected cell (52, 53).
5′-TOP mRNA degradation by the P-body–associated decay
machinery would explain both the increased decay of these
mRNAs and the increased cap-snatching of these mRNAs dur-
ing infection, because RVFV competes with the decapping ma-
chinery for targets in these compartments (Fig. 5E). Altogether,
these activities would result in a loss of 5′-TOP mRNAs, which
would have two clear consequences. First, it would lead to de-
creased levels of the 5′-TOP mRNAs encoding the translational
machinery, ultimately inhibiting global translation as ribosomal
proteins and other translation factors become depleted, consis-
tent with observations that RVFV-induced global translational
shutoff is slow and occurs at late time points (27).
Second, this increased mRNA decay would result in the dis-
persal of visible RNA granules, while the mRNA degradation
machinery remained active. P bodies require RNA moieties to
nucleate and maintain their visible structural integrity, and this
can be compromised by RNase treatment of cells or by driving
RNA decay via ectopic expression of the decapping machinery
(34, 39). Viral infections can lead to complex interactions with
RNA granules (54, 55). Some viruses, including poliovirus, en-
code proteases that degrade protein components of RNA gran-
ules; loss of these nucleation factors impedes granule architec-
ture (38). Other viruses use RNA granule proteins for their own
replication; flaviviruses including West Nile virus, dengue virus,
and hepatitis C virus bring nucleation factors to sites of repli-
cation, resulting in defects in stress granule and P-body assembly
(56–58). Because we see no effects of RVFV infection on P-body
or stress granule protein stability, and no relocalization or novel
granule structures forming in infected cells, the dispersal of P
bodies and stress granules by RVFV is through a different
mechanism. In this case, sensing of RVFV infection leads to
activation, rather than inhibition, of mRNA decay and the ulti-
mate dispersal of RNA granules. Indeed, cellular mRNA decay
is induced by γ-herpesviruses and the severe acute respiratory
syndrome coronavirus, although it is generally thought that this is
mediated by direct degradation of host mRNAs by viral proteins
(55, 59–62). The decay of cellular mRNAs is thought to promote
viral replication because this alleviates the competition between
cellular mRNAs and viral mRNAs for the cellular translation
machinery (55). In contrast, our data suggest that 5′-TOP mRNA
decay hinders viral replication by attenuating translation.
Thus, incorporation of 5′-TOPs into viral mRNAs may impact
the efficiency of viral mRNA translation in multiple ways. First,
viral mRNAs containing a 5′-TOP may be sent to sites of decay
and cap-snatching, attenuating their ability to be translated; in-
deed, studies have shown that bunyaviruses can snatch their own
5′ ends (63), suggesting that viral mRNAs may be retargeted to
sites of viral cap-snatching. Second, 4EBP-dependent changes in
the translation machinery will make these 5′-TOPs poor sub-
strates for translation. Last, as 5′-TOP mRNAs encoding the
translation machinery are degraded, global effects on the core
translational machinery will inhibit overall protein synthesis, in-
cluding that of viral mRNAs. 4EBP1/2 inhibits 5′-TOP trans-
lation through sequestering eIF4E, and the ability of eIF4E to
bind eIF4G1 is necessary to form the eIF4F complex (64). In-
terestingly, another bunyavirus, the hantavirus Sin Nombre virus,
compensates for changes in the translation initiation machinery,
in particular eIF4F, by directly recruiting scanning ribosomes via
its nucleocapsid protein (65). Therefore, it is possible that this
function of the Sin Nombre nucleocapsid protein evolved as a
means to circumvent the inhibitory action of 4EBP1/2. Whether
RVFV or other bunyaviruses are also able to do this is unknown.
Our data also shed light on the interplay between cytoplasmic
cap-snatching and the decay machinery. Although we found that
RVFV snatches coregulated mRNAs in both insect and human
hosts, the cohorts of genes are distinct. In human cells, the
predominant group are 5′-TOP mRNAs, whereas in insects we
found that cell cycle-related genes were targeted (16). This ex-
pands our knowledge of RNA regulation and coordinate regu-
lation of RNA stability, defining another set of targets for the
decapping machinery (44). Indeed, our data suggest that NUDT16
selectively degrades 5′-TOP mRNAs. Whether this is due to en-
zymatic specificity, compartmentalization of the enzymes, or dif-
ferential use of cofactors is an open question.
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Although many viral infections lead to attenuation of mTOR
signaling (66, 67), it is unclear whether this is a more general
antiviral response to infection. In particular, 4EBP1/2 promotes
rather than restricts vesicular stomatitis virus, Sindbis virus, in-
fluenza virus, and encephalomyocarditis virus infection (24).
Indeed, 4EBP1/2-deficient mice are generally refractory to RNA
virus infection due to increased type I IFN responses, including
higher expression of IRF-7 (24, 68). 4EBP1/2 also negatively
regulates the translation of many innate immune effector
mRNAs, until released by mTOR signaling (68). Altogether,
these data suggest that the restriction of RVFV by 4EBP is
specific and only possible because RVFV blocks IFN activity (10).
Nevertheless, the discovery that mTOR lies at the heart of this
antiviral mechanism against RVFV is therapeutically promising.
There are no Food and Drug Administration (FDA)-approved
vaccines or antiviral therapeutics to treat bunyaviral infections,
whereas mTOR inhibitors are FDA approved and in use, espe-
cially for cancer treatments. Although rapamycin is the classical
inhibitor, it does not block all mTOR functions. In contrast,
ATP-competitive inhibitors, including Torin 1, have been shown
to inhibit all mTORC1 functions, including the 4EBP1/2 axis of
translational control (23, 69). Therefore, we hypothesize that
mTOR ATP-competitive inhibitors would boost this anti-RVFV
response and attenuate infection in three ways: first, through the
activation of antiviral autophagy (29); second, by enforcing the
incorporation of 5′-TOP UTRs into viral mRNAs during a period
where they are translationally inhibitory; and third, by promoting
and enforcing translational shutdown.
Experimental Procedures
Replicates and Statistical Analyses. All replicates shown are biological repli-
cates. Error bars are SD from the mean of n = 3 or 4 independent biological
replicates. Statistics are calculated using Student’s unpaired t test with un-
equal variance, for all experiments other than the linear regression analysis
in Fig. 2 A–C (see analysis below). Results were considered significant if
P < 0.05.
Cells, Viruses, Antibodies, and Reagents. U2OS cells and MEFs were grown and
maintained as previously described (70, 71). MP12 strain of RVFV was grown in
Vero cells as described (72). Antibodies were obtained from the following
sources: anti-GFP (Invitrogen), anti-tubulin (Sigma), anti-RVFV N ID8 and anti-
RVFV Gn 4D4 (gifts from R. Doms, University of Pennsylvania, Philadelphia),
anti-Rck/DDX6 (MBL), anti-RPS3A (Abcam; ab96524), anti-RPS8 (Abcam;
ab13803), anti-DCP1a (Abcam; ab47811), anti-TIAR (BD Biosciences; BD610352),
anti-eIF4G (Santa Cruz; sc-11373), and anti-G3BP (BD Biosciences; BDB611126). All
other primary antibodies were from Cell Signaling: p-S6(S240/244) (catalog
#2215), S6 (catalog #2317), 4EBP (catalog #9452), p-4EBP(T37/46) (catalog #2855),
Akt (catalog #9272), and p-Akt(S473) (catalog #9271). Fluorescent secondary
antibodies were obtained from Invitrogen, and HRP-conjugated antibodies were
from Amersham. Additional chemicals were obtained from Sigma.
siRNA. U2OS cells were seeded on six-well plates in 2 mL of complete DMEM,
and then transfected with the indicated siRNA using HiPerfect transfection
reagent in OptiMEM at a final concentration of 20 nM. Two siRNAs were
pooled for each gene targeted. Cells were incubated for 3 d and then infected
as described. siRNAs were from Ambion; sequences are available in SI
Experimental Procedures.
Plasmids. FLAG-NUDT16 plasmid was a gift from M. Kiledjian, Rutgers Uni-
versity, Piscataway, NJ. The following plasmids were obtained from Addg-
ene: GFP-DCP2 (catalog #25031); TOP-WT (catalog #38235); and TOP-MUT
(catalog #38236).
Reporter Assays. U2OS cells were transfected with 0.04 μg of TOP-WT or TOP-
MUT plasmids (23) obtained from Addgene (38235 and 38236) and 0.96 μg
of empty vector (pcDNA3.1+), FLAG-NUDT16, or GFP-DCP2 using Xtreme-
gene 9 according to the manufacturer’s instruction. Twenty-four hours
posttransfection, cells were uninfected or infected with RVFV (MOI, 5) and
harvested 16 or 24 h later. Luciferase expression was quantified using the
Renilla-GLO Luciferase Assay System (Promega) according to the manufac-
turer’s directions.
Immunofluorescence. For percent infection quantification, cells were fixed,
processed, imaged by automated microscopy [at least three wells per con-
dition at least three sites per well (ImageXpressMicro; 10×)] and subject to
automated image analysis using MetaXpress as described (73).
For RNA granule analysis, U2OS cells were seeded on coverslips, infected
with RVFV, fixed, and processed for fluorescent microscopy (Leica DMI 4000 B
fluorescent microscope; 63×). Where indicated, cells were treated with
0.5 mM As2O3 to induce RNA granules, which were quantified by automated
imaged analysis (MetaXpress granule module).
RNA Analysis. Total RNA was extracted as previously described (74). RT-qPCR
was performed as previously described (75). Primer sequences are described
in SI Experimental Procedures.
Immunoblot. Total protein was collected in RIPA buffer and analyzed by
reducing SDS/PAGE gel as previously described (72). Representative blots
from ≥3 experiments shown.
ActD Treatment. U2OS cells were infected with RVFV (MOI, 1) for 17 h then
treated with ActD (5 μg/mL) for the indicated number of hours. Total RNA
was collected at each time point and analyzed by RT-qPCR. Statistical sig-
nificance was assessed by fitting a linear model to each decay curve with
explanatory variables of experimental replicate, infection, and linear or
squared time; only infection showed a significant effect by ANOVA at 19 df,
P < 0.001.
5′-RACE and Cloning. 5′-RACE was performed using the FirstChoice RLM-RACE
kit from Ambion according to the manufacturer’s instruction. RT-PCR was
performed as described (75) using primers specific for the 5′-RACE adaptor
(forward) and RVFV N transcript (reverse), and gel purified (Qiagen) before
ligation using TOPO TA cloning system (Invitrogen).
BOWTIE Analysis of Human 5′-RACE Sequences. Snatched sequences were
mapped to the Hg19 genome with Bowtie, using a seed length of 12 and
allowing zero mismatches. The resulting regions were intersected with the
coordinates of annotated human 5′-UTRs, downloaded from University of
California, Santa Cruz (Hg19). The 5′-UTRs were then manually inspected to
verify the presence of the snatched sequence near the transcriptional start
site. If multiple matches were present, distance from the annotated tran-
scriptional start site was used to determine the more likely match.
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